Home
/

Mugwort Tea: What It Does and Who Should Avoid It

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
Last updated
June 7, 2026
Key takeaway:

Mugwort tea (Artemisia vulgaris) is a centuries-old herbal infusion now trending for vivid dreams and menstrual support, but controlled human trials are essentially absent for both claims. The most consequential fact: thujone constituents have demonstrated effects on placental cell metabolism, which is why it's contraindicated in pregnancy at any preparation strength.

Read more →
Table of contents

What Mugwort Tea Is

Mugwort tea is a hot infusion of dried Artemisia vulgaris leaf steeped in water. It has been used for centuries in European herbalism and Traditional Chinese Medicine (TCM). Modern wellness marketing positions it for vivid dreams, menstrual comfort, and digestive support. It contains thujone (a GABA-A modulating terpene also studied in absinthe research), a compound with real pharmacological activity and a documented safety profile.

Mugwort's current resurgence tracks closely with the 2020–2023 TikTok dream-supplement wave, where "ancient herb" content merged with sober-curious psychoactive interest and herbal-feminist menstrual-care communities. The plant had been quietly present in TCM and European folk medicine for centuries before the algorithm found it.

The claims most commonly attached to mugwort tea include:

  • Vivid or lucid dreams (psychoactive / GABA-adjacent claim)
  • Menstrual cycle regulation and "comfort" (uterotonic / traditional claim)
  • Digestive bitter / appetite stimulation
  • Anti-inflammatory / antioxidant support

Inside the Steeped Leaf

The active fraction in mugwort tea is the dried leaf of Artemisia vulgaris. Its constituent chemistry drives both the traditional claims and the safety concerns worth understanding before steeping.

Artemisia vulgaris (common mugwort) leaf

Artemisia vulgaris belongs to the Asteraceae family, the same botanical family as ragweed and chrysanthemum. Key constituents include thujone (α- and β-isomers), sesquiterpene lactones, flavonoids, and essential-oil terpenoids that collectively account for both the pharmacological interest and the toxicological caution. The broader Artemisia genus shares many of these bioactive classes, though most detailed pharmacology data comes from related species rather than A. vulgaris specifically. Asteraceae membership is clinically relevant: mugwort cross-reactivity with ragweed, celery, and several spices is well-documented. The form used in the current wellness trend is dried leaf, typically 1–2 teaspoons per 8 oz steep.

How Mugwort Is Proposed to Work

Two mechanisms appear repeatedly in herbalist content: "uterotonic" and "psychoactive." The biology behind each is real, but the human evidence for both stops well short of what the marketing implies.

The first proposed mechanism is uterotonic action. Thujone-containing constituents have been shown in preclinical work to affect smooth-muscle contractility. Thujone has also been shown to disrupt placental cell metabolism in human choriocarcinoma cell models. Detoxification of α- and β-thujone varies across species and metabolic contexts, which complicates direct extrapolation to human tea drinkers. This is the biological plausibility behind both the traditional menstrual-regulation claim and the pregnancy contraindication. The second proposed mechanism is GABA-A receptor modulation: α-thujone has been shown to modulate the GABA-A receptor, which is the proposed pathway for psychoactive and dream-related effects. The closest human pharmacology data comes from a controlled absinthe study showing attention and mood effects from high-dose thujone, far above typical mugwort-tea levels. The mechanism is biologically plausible at sufficient thujone exposure; outcome evidence at typical tea-strength doses remains sparse.

What the Human Evidence Shows

The marketed claims for mugwort tea span menstrual support, vivid or lucid dreams, breech presentation (via moxibustion, distinct from the tea), and digestive or anti-inflammatory benefits.

Mugwort tea regulates menstrual cycles / supports menstrual comfort: Limited (largely traditional / ethnobotanical)

Traditional use of Artemisia vulgaris for menstrual support is centuries deep across multiple herbal traditions. Modern controlled human trials on oral mugwort tea for menstrual outcomes are essentially absent. Mechanistic plausibility from thujone's smooth-muscle effects supports the proposal but not the clinical outcome. Traditional use is well-documented; controlled human evidence is not. "Traditionally used to support menstrual comfort" is the accurate framing, not "treats menstrual cramps."

Mugwort tea produces vivid / lucid dreams: Anecdotal

No controlled trials have measured dream outcomes from oral mugwort tea. GABA-A modulation provides mechanistic plausibility, but the closest human data involves thujone doses far exceeding those in a typical cup. At standard steep strength, the dream claim is anecdotal. Pushing the preparation stronger is not a solution: a documented acute thujone poisoning case resulted from repeated ingestion of a concentrated A. vulgaris infusion.

Mugwort moxibustion supports breech presentation (DISTINCT from tea): Moderate (moxibustion only, NOT oral tea)

The most rigorous clinical literature on Artemisia vulgaris concerns moxibustion: burning dried mugwort near acupoint BL67 to encourage cephalic version in breech presentation. A Cochrane systematic review found some evidence supporting moxibustion for breech presentation, and a separate meta-analysis reinforced the same signal. This evidence base is for smoke and heat application, not for drinking mugwort tea. Oral tea does not inherit the moxibustion evidence base.

Mugwort tea has anti-inflammatory / digestive benefits: Animal-only / Preclinical

An in vivo carrageenan-induced paw-edema model demonstrated anti-inflammatory activity for A. vulgaris and β-caryophyllene oxide. A compound isolated from A. vulgaris reduced LPS-induced inflammation in cell and zebrafish models. In vitro work has also shown antidiabetic and anti-inflammatory potential. But none of this is human evidence at oral tea doses. The mechanism is plausible; the clinical outcome in humans is unestablished.

How Mugwort Tea Is Traditionally Brewed

The traditional preparation is straightforward. Steeping time and leaf quantity are the two variables that most directly affect both flavor and the concentration of thujone-containing compounds.

Ingredients

  • Dried mugwort leaf (Artemisia vulgaris): 1–2 teaspoons
  • Boiling water: 8 oz (240 mL)

Preparation

  1. Add the dried mugwort to a tea infuser or directly to a cup.
  2. Pour just-off-boil water over the leaf.
  3. Steep for 5–10 minutes; longer steeping increases bitterness and concentration of thujone-containing compounds.
  4. Strain and drink.

Common variations blend mugwort with milder herbs (chamomile, lemon balm) to soften the bitterness.

A note on concentration: Steeping time directly affects thujone load. Longer steeps and higher leaf-to-water ratios push the preparation toward the psychoactive range. A documented poisoning case resulted from repeated ingestion of a concentrated A. vulgaris infusion. This is not a preparation to make stronger. Mugwort tea should never be consumed during pregnancy at any strength.

Safety, Pregnancy Contraindications, and the Thujone Concern

Mugwort tea is contraindicated in pregnancy and in anyone actively trying to conceive. Thujone and related uterotonic constituents have demonstrated effects on placental cell metabolism, and Artemisia species carry a long ethnobotanical association with fertility regulation. This is not a footnote; it is the primary safety concern for this herb.

Theoretical drug interactions include anticonvulsants and sedative-hypnotics via thujone-mediated GABA-A modulation. Anticoagulant interactions are also theoretically possible via the broader flavonoid load in Artemisia preparations. Discuss any chronic medication with your prescribing clinician before starting daily mugwort tea.

Anyone with an Asteraceae allergy should avoid mugwort tea entirely. The mugwort-celery-spice syndrome involves cross-reactivity with celery, carrot, and several culinary spices, and co-sensitization patterns in mugwort-allergic patients continue to be characterized in current clinical research. Population-level IgE-reactivity data show mugwort is a recognized aeroallergen, though a less common sensitizer than grass or birch pollen. Children and elderly individuals face additional risk from higher-concentration preparations, where psychoactive thujone exposure is more likely.

Acute thujone poisoning from repeated A. vulgaris infusion ingestion has been documented in a human case report. Regulatory toxicology benchmarks for thujone-containing herbal preparations establish that safe exposure thresholds are narrow and preparation-dependent.

Biomarker interaction warning. Mugwort tea consumption near a hormone-panel draw may confound interpretation if uterotonic effects are exerting a real cycle-phase influence, but there is no established lab-test interference. Schedule mugwort tea use and hormone panels in coordination with the ordering clinician. Pausing the tea at least 24 hours before any thujone-relevant toxicology screen is commonly advised; confirm with the ordering clinician.

The named contraindications, summarized:

  • Pregnancy / trying to conceive. Clinician sign-off first, and the standard guidance is to avoid entirely. Uterotonic and placental-cell concerns are documented.
  • Asteraceae allergy (ragweed, celery, mugwort-celery-spice syndrome). Avoid.
  • Anticonvulsant / sedative-hypnotic users. Discuss with prescriber; theoretical GABA-A interaction.
  • High-concentration / long-steep preparations. These move from traditional tea into the psychoactive and toxic range. A documented acute thujone poisoning case exists.
  • Biomarker-panel interaction. Pause before relevant hormone or toxicology panels per ordering clinician.

If any of this applies, the right next step is a clinician, not the next TikTok recipe.

Biomarkers Worth Running Before Reaching for a Menstrual Tea

If menstrual irregularity or persistent low mood is the reason for reaching for mugwort tea, the underlying biology is often an ovarian-axis, thyroid, or ferritin question, not a tea question. A baseline panel surfaces those drivers and tells you whether the felt symptom is downstream of something a clinical workup can address.

  • Estradiol: Cycle-phase-timed measurement reveals whether menstrual irregularity has an underlying ovarian-axis explanation. A clinical estradiol pattern points toward a clinical workup, not a tea.
  • Progesterone (mid-luteal): Mid-luteal progesterone helps indicate whether ovulation is likely occurring. The traditional "menstrual regulation" claim targets cycles that may have an ovulatory issue worth identifying directly.
  • TSH: Thyroid dysfunction is a common and treatable cause of cycle irregularity and mood changes. Worth ruling out before attributing the issue to anything else.
  • Ferritin: Low ferritin from heavy menstrual bleeding is common and contributes to fatigue and mood symptoms that no tea will address.

If estradiol, progesterone, TSH, and ferritin reveal an underlying pattern, that pattern is the clinical question. If they're unremarkable, that's information too, and helps the conversation with a clinician focus on what the felt experience may actually be about.

Where Mugwort Tea Fits

Mild mugwort tea may reasonably suit non-pregnant adults who enjoy the ritual and are drawn to the bitter digestive tradition. People with no Asteraceae allergy, no sedative or anticonvulsant use, and no active reproductive health concerns are the lowest-risk candidates. Even then, "may suit" is the right framing, not "will benefit."

Anyone who is pregnant, trying to conceive, or actively planning conception should not use mugwort tea. Anyone reaching for it because of chronic menstrual irregularity, suspected hormone dysregulation, or persistent low mood is addressing the wrong layer of the biology. Those are clinical evaluations.

Stronger Levers for the Same Outcomes

For each of the main reasons people reach for mugwort tea, better-evidenced alternatives exist.

Clinical evaluation of cycle irregularity. If the reason for mugwort tea is menstrual irregularity, a cycle-phase-timed workup (estradiol, progesterone, TSH, prolactin, and AMH where fertility is relevant) has substantially stronger evidence than any herbal infusion. First-line clinical menstrual management ranges from cycle-tracking education to targeted hormonal options depending on the underlying cause.

Validated dream practices (sleep hygiene, dream journaling, REM-supportive routines). The lucid-dream claim for mugwort sits at anecdotal evidence. Sleep-hygiene interventions and dream-journaling have stronger behavioral-research support for dream recall and quality, without any thujone exposure.

Mild bitter digestives that lack the thujone safety axis. If the appeal is the bitter digestive angle, herbs like gentian or dandelion root carry a similar bitter profile without the uterotonic thujone load. These still warrant caution in pregnancy but lack the documented uterotonic flag specific to Artemisia vulgaris.

Measure the Underlying Biology Before Reaching for a Tea

Wellness rituals are inexpensive to try. That's a feature, but for menstrual or mood concerns, it also means you may be addressing the wrong layer of the biology entirely. Trends that target real biomarkers have an objective answer; a menstrual tea is downstream of the biology, not the lever that moves it.

If you're reaching for mugwort tea because of cycle irregularity (fewer than 8 cycles per year, cycle length over 35 days, or intermenstrual bleeding), suspected hormone dysregulation, or persistent low mood, that's an OB/GYN or primary-care evaluation, not a steeping question.

Measuring the lever before pulling it, then measuring again, is foundational to Superpower's approach to preventive health.

The Honest Verdict on Mugwort Tea

Mugwort tea is a centuries-old infusion of Artemisia vulgaris with a thin modern human-evidence base and a non-negotiable pregnancy contraindication. The most rigorous clinical evidence on Artemisia vulgaris is for moxibustion: smoke and heat, not oral tea. For non-pregnant adults without Asteraceae allergy who enjoy the ritual, mild tea is a low-risk tradition. Pushed-strength preparations move into thujone toxicity territory documented in case reports. The more useful question than "how strong should I steep" is "what's the underlying biology I'm trying to address", and that is a measurable question. Test first, talk to a clinician, then decide.

FAQs

For common consumer claims like vivid dreams, menstrual regulation, and digestion, mugwort tea evidence is limited to anecdotal reports. The most rigorous clinical research on Artemisia vulgaris involves moxibustion for breech presentation, which is burning the herb rather than drinking it as tea, making it distinct from oral consumption.

Mugwort tea is traditionally used to support menstrual comfort, but modern controlled human evidence for oral mugwort tea on menstrual outcomes is essentially absent. The traditional menstrual claim is based on uterotonic thujone-containing constituents, which also underlie pregnancy contraindications.

The lucid dream effect of mugwort tea is primarily anecdotal and lacks strong scientific support at typical brewing strengths. While mugwort contains thujone, which can modulate GABA-A receptors, psychoactive effects including changes in attention and mood occur at doses much higher than typical tea, where safety risks also increase.

References

  1. Ekiert, H., Pajor, J., Klin, P., Rzepiela, A., Ślesak, H., & Szopa, A. (2020). Significance of Artemisia Vulgaris L. (Common Mugwort) in the History of Medicine and Its Possible Contemporary Applications Substantiated by Phytochemical and Pharmacological Studies. Molecules (Basel, Switzerland), 25(19). https://doi.org/10.3390/molecules25194415
  2. Ekiert, H., Klimek-Szczykutowicz, M., Rzepiela, A., Klin, P., & Szopa, A. (2022). Artemisia Species with High Biological Values as a Potential Source of Medicinal and Cosmetic Raw Materials. Molecules (Basel, Switzerland), 27(19). https://doi.org/10.3390/molecules27196427
  3. Lee, J. Y., Park, H., Lim, W., & Song, G. (2020). α,β-Thujone suppresses human placental choriocarcinoma cells via metabolic disruption. Reproduction (Cambridge, England), 159(6), 745-756. https://doi.org/10.1530/REP-20-0018
  4. Höld, K. M., Sirisoma, N. S., & Casida, J. E. (2001). Detoxification of alpha- and beta-Thujones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo. Chemical research in toxicology, 14(5), 589-95. https://doi.org/10.1021/tx000242c
  5. Höld, K. M., Sirisoma, N. S., Ikeda, T., Narahashi, T., & Casida, J. E. (2000). Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences of the United States of America, 97(8), 3826-31. https://doi.org/10.1073/pnas.070042397
  6. Dettling, A., Grass, H., Schuff, A., Skopp, G., Strohbeck-Kuehner, P., & Haffner, H. T. (2004). Absinthe: attention performance and mood under the influence of thujone. Journal of studies on alcohol, 65(5), 573-81. https://doi.org/10.15288/jsa.2004.65.573
  7. Di Lorenzo, C., Ferretti, F., Moro, E., Ceschi, A., Colombo, F., Frigerio, G., Lüde, S., & Restani, P. (2018). Identification and Quantification of Thujone in a Case of Poisoning Due to Repeated Ingestion of an Infusion of Artemisia Vulgaris L. Journal of food science, 83(8), 2257-2264. https://doi.org/10.1111/1750-3841.14273
  8. Coyle, M. E., Smith, C., & Peat, B. (2023). Cephalic version by moxibustion for breech presentation. The Cochrane database of systematic reviews, 5(5), CD003928. https://doi.org/10.1002/14651858.CD003928.pub4
  9. Liao, J. A., Shao, S. C., Chang, C. T., Chai, P. Y., Owang, K. L., Huang, T. H., Yang, C. H., Lee, T. J., & Chen, Y. C. (2021). Correction of Breech Presentation with Moxibustion and Acupuncture: A Systematic Review and Meta-Analysis. Healthcare (Basel, Switzerland), 9(6). https://doi.org/10.3390/healthcare9060619
  10. Kumar, G. S., Sholapuri, P., K, D., Shaily Enugonda, M., & B P, G. (2025). Drug and chemical toxicology, 48(2), 426-439. https://doi.org/10.1080/01480545.2024.2415349
  11. Zhao, Z., Lin, S., Liu, T., Hu, X., Qin, S., Zhan, F., Ma, J., Huang, C., Huang, Z., Wang, Y., Zheng, K., Zhang, W., & Ren, Z. (2024). Artemvulactone E isolated from Artemisia vulgaris L. ameliorates lipopolysaccharide-induced inflammation in both RAW264.7 and zebrafish model. Frontiers in pharmacology, 15, 1415352. https://doi.org/10.3389/fphar.2024.1415352
  12. Neagu, E., Paun, G., Albu, C., Apreutesei, O. T., & Radu, G. L. (2023). In Vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies. Molecules (Basel, Switzerland), 28(20). https://doi.org/10.3390/molecules28207156
  13. Kamboj, V. P., & Dhawan, B. N. (1982). Research on plants for fertility regulation in India. Journal of ethnopharmacology, 6(2), 191-226. https://doi.org/10.1016/0378-8741(82)90004-690004-6)
  14. Anliker, M. D., Borelli, S., & Wüthrich, B. (2002). Occupational protein contact dermatitis from spices in a butcher: a new presentation of the mugwort-spice syndrome. Contact dermatitis, 46(2), 72-4. https://doi.org/10.1034/j.1600-0536.2002.460202.x
  15. Scala, E., Cusa, G., Villella, V., Abeni, D., Giani, M., Guerra, E. C., Locanto, M., Meneguzzi, G., Pirrotta, L., Quaratino, D., Zaffiro, A., Caprini, E., Barrale, M., Brusca, I., Pravettoni, V., Cecchi, L., Villalta, D., Aumayr, M., Mittermann, I., ... Asero, R. (2025). Art v 1 and Amb a 4 Co-Sensitization Identifies Italian Patients at Risk for Mugwort-Celery-Spice Syndrome. Allergy. https://doi.org/10.1111/all.70195
  16. Majkowska-Wojciechowska, B., Kulma, M., & Kurowski, M. (2025). Aeroallergen IgE-Reactivity Patterns and Respiratory Allergy in Children and Adults: A Retrospective Study in 1711 Patients from the Central Poland Urban Area. Medicina (Kaunas, Lithuania), 61(9). https://doi.org/10.3390/medicina61091676
  17. Pelkonen, O., Abass, K., & Wiesner, J. (2013). Thujone and thujone-containing herbal medicinal and botanical products: toxicological assessment. Regulatory toxicology and pharmacology : RTP, 65(1), 100-7. https://doi.org/10.1016/j.yrtph.2012.11.002

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey